BLUX yields 0.96% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, BLUX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BLUX + MRK for your $10,000?
BLUX seeks growth of capital through investments in shares of unaffiliated ETFs. It provides exposure to the domestic equity market by actively managing a portfolio of funds primarily invested in US companies. To back its total market claim, the fund-of-funds is diversified by market-cap, allowing exposure to small-, mid-, and large-caps. There are no limitations on investment styles or other factor tilts such as growth, value, and quality. In selecting constituents, the fund utilizes a combination of top-down and bottom-up investment approach to identify securities believed to be reasonable representatives, priced fairly, and reflects relative performance in comparison to similar ETFs. Note, however, that due to the funds active management, final investment decisions are at the discretion of the adviser, which may or may not include exposure to international securities.
Full BLUX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.